TY  - JOUR
PY  - 2017//
TI  - Use of antidepressant medication in pregnancy and adverse neonatal outcomes: a population-based investigation
JO  - Pharmacoepidemiology and drug safety
A1  - Cantarutti, Anna
A1  - Merlino, Luca
A1  - Giaquinto, Carlo
A1  - Corrao, Giovanni
SP  - 1100
EP  - 1108
VL  - 26
IS  - 9
N2  - BACKGROUND: Untreated depression and antidepressant use during pregnancy may have negative consequences for births. There are still conflicting data on the potential harmful effects of prenatal antidepressant treatment on child health. <br><br>OBJECTIVE: To investigate the relationship between the use of antidepressant medication during pregnancy and selected neonatal outcomes. <br><br>METHODS: A population-based cohort study including 9825 deliveries exposed to an antidepressant between 9 months before last menstrual date through to delivery, from January 2005 to December 2010 in the Lombardy region of Italy, was conducted. We evaluated the prevalence ratio (PR) of low Apgar score, small for gestational age, intrauterine hypoxia and birth asphyxia, neonatal convulsion, and other respiratory conditions, among infants born to mothers exposed to an antidepressant during pregnancy using log-binomial regression analysis. Fine stratification was applied to the propensity score to account for all potential confounders. Sensitivity and subgroup analyses restricted to specific types of antidepressant, time of exposure, and women with vaginal deliveries and full-term births were also performed. <br><br>RESULTS: A total of 33.4% of women filled at least one prescription during pregnancy. Compared to infants born to mothers with exposure to antidepressants only before pregnancy, those with exposure to antidepressants during pregnancy had an increased prevalence ratio of a low Apgar score (PR, 1.63, 95% CI, 1.01-2.61), intrauterine hypoxia and birth asphyxia (aPR, 1.37, 1.08-1.73), neonatal convulsion (aPR, 2.81, 1.07-7.36), and other respiratory condition (aPR, 1.24, 1.00-1.52). <br><br>RESULTS were similar in the sensitivity and subgroup analyses. <br><br>CONCLUSIONS: Use of antidepressants during pregnancy may have an increased risk for several neonatal outcomes. KEY POINTS In this population-based cohort study, we found a significant increase in the prevalence ratio of low Apgar score, intrauterine hypoxia and birth asphyxia, neonatal convulsion, and other respiratory conditions among who were exposed in utero to antidepressant drugs. These effects seem to be attributable to the treatment rather than to the disease itself. Further researches are needed to evaluate the longer-term developmental outcomes.<br><br>Copyright © 2017 John Wiley & Sons, Ltd.<p />  <p>Language: en</p>
LA  - en
SN  - 1053-8569
UR  - http://dx.doi.org/10.1002/pds.4242
ID  - ref1
ER  -